These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10374931)

  • 1. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
    Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R
    Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of TH-142177, a novel orally active AT1-receptor antagonist.
    Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Miyake H; Yamada S; Kimura R
    Fundam Clin Pharmacol; 1997; 11(5):395-401. PubMed ID: 9342592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
    Briand V; Riva L; Galzin AM
    Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways.
    Kyotani Y; Zhao J; Tomita S; Nakayama H; Isosaki M; Uno M; Yoshizumi M
    J Pharmacol Sci; 2010; 113(2):161-8. PubMed ID: 20508392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated.
    van Kleef EM; Fingerle J; Daemen MJ
    Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):857-63. PubMed ID: 8673560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
    Iouzalen L; Stepien O; Marche P
    J Pharmacol Exp Ther; 1999 Apr; 289(1):181-7. PubMed ID: 10087002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist.
    Hong KW; Kim CD; Lee SH; Yoo SE
    Fundam Clin Pharmacol; 1998; 12(1):64-9. PubMed ID: 9523186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
    Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
    Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells.
    Sachinidis A; el-Haschimi K; Ko Y; Seul C; Düsing R; Vetter H
    Biochem Pharmacol; 1996 Jul; 52(1):123-6. PubMed ID: 8678895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
    Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
    Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists.
    Dubey RK; Flammer J; Lüscher TF
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2067-75. PubMed ID: 9761285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro.
    Herbert JM; Delisée C; Dol F; Schaeffer P; Cazaubon C; Nisato D; Chatelain P
    Eur J Pharmacol; 1994 Jan; 251(2-3):143-50. PubMed ID: 8149971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury.
    Prescott MF; Webb RL; Reidy MA
    Am J Pathol; 1991 Dec; 139(6):1291-6. PubMed ID: 1750504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin receptor expression is increased by angiotensin II in cultured and native vascular smooth muscle cells.
    Fisslthaler B; Schini-Kerth VB; Fleming I; Busse R
    Cardiovasc Res; 1998 Apr; 38(1):263-71. PubMed ID: 9683930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
    Koh E; Morimoto S; Tomita J; Rakugi H; Jiang B; Inoue T; Nabata T; Fukuo K; Ogihara T
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):175-9. PubMed ID: 7511744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.
    Kawamura M; Terashita Z; Okuda H; Imura Y; Shino A; Nakao M; Nishikawa K
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1664-9. PubMed ID: 8371164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.
    Dunn FW; Roux MH; Farhadian F; Sabri K; Ossart C; Samuel JL; Rappaport L; Hamon G
    J Pharmacol Exp Ther; 1997 Jan; 280(1):447-53. PubMed ID: 8996227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery.
    Kim S; Kawamura M; Wanibuchi H; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Iwao H
    Circulation; 1995 Jul; 92(1):88-95. PubMed ID: 7788922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.